InsidersTradesSigma
Mendus AB Stock: price and insider trades · Finland · FIN-FSA
Track the Mendus AB stock price and the full management transaction log of the company, a publicly traded company based in Finland. Shares are quoted on FI FI, under the oversight of FIN-FSA. Operating in the Health Care sector, Mendus AB has logged 18 insider filings. The latest transaction was reported on 17 June 2026 (Purchase). Among the most active insiders: Helen Tuvesson Andersson. Every trade is accessible without an account.
18
Insider Decl.
0
Thresholds
€381,656
18 ops.
Buy Volume
·
0 ops.
Sell Volume
30Σ signal
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 17 June 2026
Declarations18 total
174,804 shares@ SEK 5.6249.4% of flowAktieFI:csv-5134051754c084a32402
Ideal exit: 9 Mar 2027 (T+270)
60,228 shares@ SEK 5.6293.3% of flowAktieFI:csv-04fabc5bb906440ca2f2
Ideal exit: 9 Mar 2027 (T+270)
2,500 shares@ SEK 5.1052.6% of flowAktieFI:csv-43f0d78f55d8afcb70c2
Ideal exit: 9 Mar 2027 (T+270)
2,272 shares@ SEK 5.1047.4% of flowAktieFI:csv-5cb62e7194beec084a3b
Ideal exit: 8 Mar 2027 (T+270)
72,388 shares@ SEK 5.1550.0% of flowAktieFI:csv-a56bee36a0b21c1479d7
Ideal exit: 2 Feb 2027 (T+270)
72,388 shares@ SEK 5.168100.0% of flowAktieFI:A003Y557-1
Ideal exit: 2 Feb 2027 (T+270)
15,654 shares@ €0.391225.2% of flowAktieFI:A003X591-1
Ideal exit: 5 Jan 2027 (T+270)
16,315 shares@ €0.391216.8% of flowAktieFI:A003X579-1
Ideal exit: 5 Jan 2027 (T+270)
32,189 shares@ €0.39151.3% of flowAktieFI:A003X583-1
Ideal exit: 3 Jan 2027 (T+270)
12,993 shares@ €0.473725.3% of flowAktieFI:A003V088-1
Ideal exit: 26 Sept 2026 (T+270)
55,000 shares@ €0.457866.4% of flowAktieFI:A003U944-2
Ideal exit: 12 Sept 2026 (T+270)
200,000 shares@ €0.4578100.0% of flowAktieFI:A003U933-1
Ideal exit: 12 Sept 2026 (T+270)
10,237 shares@ €0.621716.8% of flowAktieFI:A003T196-1
Ideal exit: 21 Jul 2026 (T+270)
9,822 shares@ €0.621725.1% of flowAktieFI:A003T160-1
Ideal exit: 21 Jul 2026 (T+270)
9,130 shares@ €0.6217100.0% of flowAktieFI:A003T076-1
Ideal exit: 21 Jul 2026 (T+270)
17,842 shares@ €0.670548.7% of flowAktieFI:A003Q912-1
Ideal exit: 11 Apr 2026 (T+270)
8,797 shares@ €0.675824.4% of flowAktieFI:A003Q888-1
Ideal exit: 17 Apr 2026 (T+270)
13,861 shares@ €0.4832100.0% of flowAktieFI:A003P643-1
Ideal exit: 7 Mar 2026 (T+270)
18 of 18 declarations
About Mendus AB
Mendus AB is a biopharmaceutical company focused on developing immunological treatments for cancer. It is listed on the Stockholm Stock Exchange.
